Home > Financial Ratios > ONESOURCE SPECIALTY PHARMA

ONESOURCE SPECIALTY PHARMA
Core EBITDA Growth

    Back to All Ratios
ONESOURCE SPECIALTY PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for ONESOURCE SPECIALTY PHARMA
Please provide your vote to see the results

ONESOURCE SPECIALTY PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 676.0846.82--

What is the latest Core EBITDA Growth ratio of ONESOURCE SPECIALTY PHARMA ?

The latest Core EBITDA Growth ratio of ONESOURCE SPECIALTY PHARMA is 676.08 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025676.08
Mar202446.82
Mar2023-
Mar2022-

How is Core EBITDA Growth of ONESOURCE SPECIALTY PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 676.08
1,344.00
Mar2024 46.82
0
Mar2023 0
0
Mar2022 0 -

Other Financial Ratios of ONESOURCE SPECIALTY PHARMA


Compare Core EBITDA Growth ratio of peers of ONESOURCE SPECIALTY PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA ₹17,804.3 Cr -7.8% -4.6% -22.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,630.0 Cr -2.6% 2.4% 14.6% Stock Analytics
DIVIS LABORATORIES ₹221,666.0 Cr 6.5% 23.3% 25.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹190,108.0 Cr 2.6% 3% 33.5% Stock Analytics
CIPLA ₹117,139.0 Cr -1.1% -0.2% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹97,990.9 Cr 2.6% -13.3% -10.7% Stock Analytics


ONESOURCE SPECIALTY PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA

-7.8%

-4.6%

-22.1%

SENSEX

1.2%

0.4%

-2.9%


You may also like the below Video Courses